Lisata Therapeutics, Inc. (LSTA) Q1 2025 Earnings Conference Call Transcript

Group 1 - Lisata Therapeutics held its Q1 2025 earnings conference call on May 8, 2025, to discuss financial results and provide a business update [1][3] - The management team present included John Menditto (VP of IR and Corporate Communications), Dr. David Mazzo (President and CEO), Dr. Kristen Buck (EVP of R&D and Chief Medical Officer), and James Nisco (SVP of Finance and Treasury and Chief Accounting Officer) [3][4] - A press release detailing the Q1 2025 financial results was issued shortly before the call, available on the company's website [4]